The Letters Hidden in Your Blood

A drop of blood looks like the most democratic substance the body produces. Red, thick, faintly metallic, identical from one person to the next. Pool a hundred donations into a single bucket and no eye could sort them. Yet beneath that uniformity sits a hidden grammar, a code written in sugar molecules too small to see, that for most of human history made the act of sharing blood almost indistinguishable from poisoning.

The code is the reason a transfusion can save a hemorrhaging mother in one bed and kill a man two rooms over. It was decided before either of them drew breath, settled by the genetic coin-flip of their parents. And it carries, encrypted in those tiny surface markers, a record of the diseases that hunted their ancestors across thousands of generations. To understand why we have blood types at all is to read a fossil that everyone carries and almost no one can see.

A puzzle of clotting and clumping

For centuries, blood transfusion was a gamble that mostly ended badly. The first documented human attempts in the 17th century, including a notorious case in which a French physician injected lamb’s blood into a feverish young man, produced results that ranged from miraculous recovery to swift, agonizing death. Nobody could explain the pattern. Two patients receiving apparently identical treatment might split into a survivor and a corpse. The blood looked the same. The outcomes were opposite.

The field stalled there, lethal and unpredictable, until a young physician in Vienna sat down with a microscope and a set of small glass dishes. In 1900, Karl Landsteiner began doing something deceptively simple: he mixed blood from his colleagues, and from himself, in various combinations and watched what happened. Most of the time nothing did. The red cells drifted in their plasma, loose and separate. But certain combinations turned visibly ugly. The cells gathered into dense clumps, knotting together like curds in spoiled milk.

Landsteiner noticed the clumping was not random. People sorted into consistent groups. Blood from one group would clump when mixed with blood from another, but never with its own kind. In 1901 he published his findings, describing three categories he labeled A, B, and O. ¹ A fourth and rarer group, AB, was identified by two of his students soon afterward. Landsteiner had stumbled onto the ABO system, the foundation of every safe transfusion that has happened since. The work was undramatic in the moment, a matter of dishes and patience, but it would eventually earn him the Nobel Prize in 1930. ²

The mechanism he had uncovered comes down to molecular jewelry. Every red blood cell is studded with antigens, short chains of sugar that project from its surface. In the ABO system, the relevant decorations are two: the A antigen and the B antigen. A person with type A carries the A antigen. Type B carries B. Type AB carries both. And type O, the most common type in much of the world, carries neither. That single distinction, the presence or absence of two sugar molecules, governs whether one person’s blood can safely enter another’s veins.

Why the wrong blood declares war

The violence of the clumping Landsteiner saw in his dishes was not a chemical curiosity. It was the immune system caught in the act. The body learns early to recognize its own antigens as self and to treat anything unfamiliar as a threat. Crucially, people carry pre-formed antibodies against the ABO antigens they lack. A type A person manufactures antibodies that patrol the bloodstream hunting for the B antigen. A type B person carries antibodies against A. Type O, lacking both antigens, carries antibodies against both.

This is why a mismatched transfusion can be catastrophic within minutes. Pour type B blood into a type A patient and the recipient’s anti-B antibodies swarm the incoming cells, latching on and triggering them to rupture. The reaction cascades. Clumps obstruct small vessels, hemoglobin spills into the bloodstream, the kidneys strain and can fail, and the patient may go into shock and die before anyone fully understands what went wrong. The clumping that looked merely strange under a microscope is, scaled up to a living body, a chemical war fought in the veins.

The logic of the system also explains its two famous escape hatches. Type O cells carry no A or B antigen for anyone’s antibodies to attack, which makes type O blood broadly safe to give. Hence the old shorthand of the universal donor. At the other end sits type AB, which carries both antigens and therefore makes antibodies against neither. A type AB person can, in principle, receive cells from any ABO group: the universal recipient. These rules are slightly simplified in practice, but they are why a single letter on a wristband can be the difference between rescue and disaster, and why blood banks treat that letter with near-religious care.

A second hidden code

ABO turned out to be only half the story. In the 1930s, Landsteiner, now working in New York, returned to the problem of hidden blood markers, this time alongside the physician Alexander Wiener. Experimenting with the blood of rhesus monkeys, they identified another antigen entirely, one that had nothing to do with the A and B sugars. They named it the Rh factor, after the rhesus animals that revealed it. ³

The Rh factor is the reason a blood type is rarely described by a letter alone. A person who carries the antigen is Rh-positive; a person who lacks it is Rh-negative. This is the plus or minus sign that turns A into A-positive or O into O-negative. And while it might seem like a footnote, the Rh factor solved one of obstetric medicine’s most heartbreaking mysteries.

The danger arises in pregnancy. When an Rh-negative mother carries an Rh-positive child, inherited from the father, the baby’s red cells can leak into the mother’s circulation, often during birth. Her immune system, encountering the foreign Rh antigen, may begin producing antibodies against it. In a first pregnancy this often causes little harm. But in a later pregnancy with another Rh-positive child, those antibodies can cross the placenta and attack the developing baby’s blood, a condition once known as hemolytic disease of the newborn. Before anyone understood the cause, it killed or disabled thousands of infants every year. ⁴

The remedy, when it finally came in the late 1960s, was almost anticlimactic in its simplicity. An injection of anti-Rh antibodies, given to the mother at the right moment, mops up the stray fetal cells before her own immune system can learn to react to them. The treatment, known as Rh immunoglobulin, has turned a once-common tragedy into something rare in countries where prenatal care is routine. A few molecules, delivered at the right time, quietly disarm a war between mother and child.

A ledger written by plagues

The deeper question lingers behind all of this clinical machinery. Why should humans come in different blood types at all? Evolution is ruthless about variation that serves no purpose. If one blood type were simply better, natural selection would have driven the others toward extinction long ago. Instead, all the major types persist, in stable proportions that vary by region but never vanish. Something has been keeping them in balance.

The leading explanation points to disease, specifically to the long arms race between human bodies and the pathogens that prey on them. The antigens decorating red cells are not exclusive to red cells; similar sugar structures appear on the surfaces of other tissues and in bodily secretions, and many microbes have evolved to grab onto them. A blood type, in other words, is also a set of molecular handles that some pathogens can grip and others cannot. Which means each type offers protection against certain infections while leaving the body more exposed to others.

Malaria offers the clearest case. Multiple studies have found that people with type O blood are partially protected against the most severe, life-threatening forms of Plasmodium falciparum malaria. ⁵ The parasite drives infected red cells to clump together and stick to blood-vessel walls and to other cells, a process called rosetting that helps it hide from the immune system and clog vital organs. Type O cells resist this rosetting; they clump less readily, which appears to blunt the disease’s worst outcomes. In regions where malaria has killed for millennia, that advantage would steadily favor type O.

But the same trait that helps against malaria seems to cost something elsewhere. Type O individuals show elevated susceptibility to severe cholera and to certain stomach ulcers linked to Helicobacter pylori infection, while other groups carry their own particular vulnerabilities and protections. ⁶ Type A has been associated with different infectious risks again. No single type wins on every front. Each is a bargain struck with a different ancient enemy, an advantage here paid for with a weakness there. That ledger of trade-offs is precisely why no one type ever swept the species. The diversity is the residue of a thousand epidemics, each pushing the population in a slightly different direction, none of them strong enough to win outright.

This is the sense in which blood type is a fossil. It records, in the proportions that survive in each population, which diseases pressed hardest on which ancestors. A region scourged by malaria carries the imprint of that pressure in elevated rates of type O. The blood remembers wars its current owners never fought.

The type that is not entirely yours

There is a final twist that unsettles the idea of a blood type as something fixed and personal. Those defining antigens, the A and B sugars, are not purely a product of the body that displays them. The immune memory that gives ABO its lethal edge is shaped in part by the bacteria that colonize the gut in infancy, microbes whose own surface molecules resemble the A and B antigens closely enough to train the immune system. In a real sense, the antibodies that would reject the wrong transfusion were schooled by the body’s microscopic tenants.

That relationship has opened an unexpected door. If bacteria can mimic blood antigens, perhaps bacterial enzymes can also remove them. In 2019, a team of researchers reported finding enzymes, drawn from microbes in the human gut, that could efficiently strip the A antigen off red blood cells, chemically converting type A blood toward something closer to universal type O. ⁷ The work is still being refined, and converting blood at scale for safe clinical use is a demanding problem. But the promise is enormous. Blood banks live in chronic shortage, forever short of the universal donor type. A reliable way to manufacture it from more common types could ease that scarcity in a way no recruitment drive ever has.

It is a strange inversion to sit with. The very clumping that made early transfusions deadly, the immune recognition that turns the wrong blood into poison, traces back partly to the microbes we carry. And those same microbes may now hand us the tools to defeat the problem they helped create.

What you hand over

Consider what has changed in a little over a century. In 1900, transfusion was closer to a curse than a cure, killing a large share of those who received it for reasons no physician could name. Today, transfusions are among the most routine of medical interventions, saving an enormous number of lives each year, supporting surgery, childbirth, cancer treatment, and the aftermath of accidents that would once have been uniformly fatal. ⁸ The clumping that baffled and killed has been domesticated into a labeling system precise enough to make the gift of blood safe.

What remains remarkable is how much that single letter carries. It is at once a practical instruction to a hospital, a constraint on who can save whom, and a line of inheritance reaching back through every ancestor who survived long enough to pass it on. When someone rolls up a sleeve to donate, the pint they give is not just red liquid. It is a fragment of an evolutionary record, a survival map drawn by malaria and cholera and a hundred forgotten plagues, handed forward to a stranger whose own hidden code happens to match. The blood looks identical to anyone else’s. The story written on its surface is not.

Sources

1. Landsteiner, K., “Über Agglutinationserscheinungen normalen menschlichen Blutes,” Wiener Klinische Wochenschrift, 1901. — https://www.nobelprize.org/prizes/medicine/1930/landsteiner/facts/
2. The Nobel Prize in Physiology or Medicine 1930, Karl Landsteiner, Nobel Foundation. — https://www.nobelprize.org/prizes/medicine/1930/summary/
3. Landsteiner, K. and Wiener, A. S., “An agglutinable factor in human blood recognized by immune sera for rhesus blood,” Proceedings of the Society for Experimental Biology and Medicine, 1940. — https://journals.sagepub.com/doi/10.3181/00379727-43-11151
4. Bowman, J., “Thirty-five years of Rh prophylaxis,” Transfusion, 2003. — https://pubmed.ncbi.nlm.nih.gov/14641860/
5. Cserti, C. M. and Dzik, W. H., “The ABO blood group system and Plasmodium falciparum malaria,” Blood, 2007. — https://ashpublications.org/blood/article/110/7/2250/24037/
6. Anstee, D. J., “The relationship between blood groups and disease,” Blood, 2010. — https://ashpublications.org/blood/article/115/23/4635/27442/
7. Rahfeld, P. et al., “An enzymatic pathway in the human gut microbiome that converts A to universal O type blood,” Nature Microbiology, 2019. — https://www.nature.com/articles/s41564-019-0469-7
8. American Red Cross, “Importance of the Blood Supply / blood facts and statistics.” — https://www.redcrossblood.org/donate-blood/how-to-donate/how-blood-donations-help/blood-needs-blood-supply.html

Related reading

• The Body's Civil War
• The Hag on the Chest

More from the Body edition →